Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
224.80
+6.01 (2.75%)
Mar 28, 2025, 3:30 PM IST

Piramal Pharma Statistics

Total Valuation

Piramal Pharma has a market cap or net worth of INR 297.96 billion. The enterprise value is 341.74 billion.

Market Cap 297.96B
Enterprise Value 341.74B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

Piramal Pharma has 1.33 billion shares outstanding. The number of shares has increased by 8.30% in one year.

Current Share Class n/a
Shares Outstanding 1.33B
Shares Change (YoY) +8.30%
Shares Change (QoQ) -7.69%
Owned by Insiders (%) 0.20%
Owned by Institutions (%) 22.91%
Float 607.58M

Valuation Ratios

The trailing PE ratio is 765.97 and the forward PE ratio is 70.54. Piramal Pharma's PEG ratio is 0.94.

PE Ratio 765.97
Forward PE 70.54
PS Ratio 3.34
PB Ratio 3.78
P/TBV Ratio 7.99
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio 0.94
Financial Ratio History

Enterprise Valuation

EV / Earnings 878.51
EV / Sales 3.82
EV / EBITDA 23.13
EV / EBIT 47.65
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.61
Debt / EBITDA 3.40
Debt / FCF n/a
Interest Coverage 1.51

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 3.24%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 13.32M
Profits Per Employee 57,896
Employee Count 6,719
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +83.74% in the last 52 weeks. The beta is 0.12, so Piramal Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.12
52-Week Price Change +83.74%
50-Day Moving Average 215.70
200-Day Moving Average 215.67
Relative Strength Index (RSI) 58.48
Average Volume (20 Days) 11,289,614

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Piramal Pharma had revenue of INR 89.49 billion and earned 389.00 million in profits. Earnings per share was 0.29.

Revenue 89.49B
Gross Profit 53.51B
Operating Income 6.48B
Pretax Income 3.69B
Net Income 389.00M
EBITDA 13.71B
EBIT 6.48B
Earnings Per Share (EPS) 0.29
Full Income Statement

Balance Sheet

The company has 4.08 billion in cash and 47.86 billion in debt, giving a net cash position of -43.78 billion or -33.02 per share.

Cash & Cash Equivalents 4.08B
Total Debt 47.86B
Net Cash -43.78B
Net Cash Per Share -33.02
Equity (Book Value) 79.07B
Book Value Per Share 59.51
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.79%, with operating and profit margins of 7.25% and 0.43%.

Gross Margin 59.79%
Operating Margin 7.25%
Pretax Margin 4.13%
Profit Margin 0.43%
EBITDA Margin 15.32%
EBIT Margin 7.25%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.05%.

Dividend Per Share 0.11
Dividend Yield 0.05%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -8.30%
Shareholder Yield -8.25%
Earnings Yield 0.13%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a